NCT04303364|Active Not RecruitingDMC
CARdiomyopathy in Type 2 DIAbetes Mellitus
CARDIATEAM
Loading search results
CARDIATEAM
Sponsor study identifier
observational
1,256
5 countries
17
Study Start
October 2, 2020
Actual (reported)Primary Completion
April 1, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
April 1, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The objective of the CARDIATEAM clinical study is to assess the uniqueness of diabetic cardiomyopathy (DCM) relative to other forms of cardiomyopathy using unsupervised clustering approaches based on deep phenotyping (clinical, imaging and biological) information.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 1, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 6, 2020
Actual (reported)March 11, 2020
Actual (reported)October 2, 2020
Actual (reported)April 1, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
April 1, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Assess the uniqueness of diabetic cardiomyopathy (DCM) relative to other forms of cardiomyopathy
Use of unsupervised clustering approaches based on deep phenotyping (clinical, imaging and biological) information
3 years
Identify the best clinical, biological, imaging and multi-OMICs predictors belonging to each identified cluster
4 years
Assess prospective health outcomes (i.e. overall mortality, cardiovascular events and cardiac function) in the diabetic cardiomyopathy cluster identified
5 years
Explore the pathophysiological and potentially causal pathways characterizing diabetic cardiomyopathy
5 years
Since CARDIATEAM aims to assess the uniqueness of DCM, it will include a group of non-diabetic non-HFpEF individuals with diversified characteristics relating to obesity, glucose intolerance and hypertension. Consequently, CARDIATEAM cohort will recruit both non-diabetic and diabetic patients with a large spectrum of demographic, metabolic and cardiac (heart failure vs. no heart failure) clinical data.
Hopital Louis Pradel
Bron, 69677, France
Cardiology Outpatient Department at Hôpital Henri Mondor.
Créteil, France
Centre Hospitalier Universitaire Grenoble Alpes
Grenoble, 38043, France
department of diabetology and nutrition, APHM
Marseille, France
Hôpital CHU- Nantes
Nantes, 44093, France
Diabetology department, Cochin Institute
Paris, 75015, France
Diabetology departement, Lariboisière Hospital
Paris, 75475, France
Plasma EDTA, Serum, Paxgene RNA, Urine
Geneviève DERUMEAUX, MD, PhD
Henri Mondor University Hospital
1,256 participants (actual enrollment reported by the registry).
First Submitted
March 6, 2020
First Posted
March 11, 2020
Study Start
October 2, 2020
Actual (reported)Impact of Prediabetes on Acute Coronary Syndrome
Contact the study team to confirm eligibility.
University Hospital Aachen
Aachen, 52074, Germany
University Hospital Heidelberg
Heidelberg, Germany
Amsterdam UMC
Amsterdam, 1100 DD, Netherlands
University Medical Center Groningen (UMCG), Cardiology/Cardio Research
Groningen, Netherlands
Academisch ziekenhuis Maastricht, Cardiology
Maastricht, Netherlands
UMC Utrecht, Cardiology (DHL)
Utrecht, Netherlands
Hospital Vall Hebrón
Barcelona, 08035, Spain
Institut D'Investigacions Biomedica August Pi I Sunyer (IDIBAPS)
Barcelona, Spain
Hospital Gregorio Marañón
Madrid, 28007, Spain
University of Dundee, Div of Molecular&Clinical Medicine
Dundee, DD1 9SY, United Kingdom
Primary Completion
April 1, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
April 1, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
May 6, 2026
Record last verified: 2026-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: